AN ACT CONCERNING OVERSIGHT AND TRANSPARENCY IN THE PRESCRIPTION OF PSYCHOTROPIC DRUGS TO CHILDREN RECEIVING BENEFITS UNDER MEDICAID.

SB 772 requires healthcare providers prescribing psychotropic medications (for mental health conditions) to Medicaid-eligible children to provide parents or guardians with FDA medication guides, explain drug risks/benefits, and discuss non-drug alternatives. It also mandates a user-friendly system for reporting medication side effects and establishes accountability standards for Connecticut's Departments of Social Services and Public Health. The bill directly affects Medicaid-covered children, their families, and healthcare providers who prescribe these medications. Its core purpose is to increase transparency, safety, and informed decision-making in pediatric mental health treatment under Medicaid.